All News

In this interview clip from our Higher Education: Research Initiatives That Deepen Our Understanding of Cannabis supplement, Reginald Gaudino, PhD explains The Cannabis Research Institute and its studies on cannabis and hemp's societal impacts, informing policy and promoting equity and research in Illinois.

Here, we bring you our top five recent articles covering a $3.6 million grant for Minnesota’s cannabis industry, kidney disease and cannabis use, banking reform, flavoalkaloids in leaves, and CBD and liver enzyme levels.

Traditional cannabis preservation methods like glass jars or plastic bags fail to address the complex biochemical processes that lead to degradation. New packaging solutions create a controlled microclimate to maintain an ideal relative humidity between 58% and 62% and manage gas exchange to prevent degradation. This technology benefits cultivators with greater product stability, processors with higher-quality starting material, and consumers who receive a consistent product.

Two organizations with opposing views recently prepared letters to the Trump Administration on the anticipated action regarding cannabis reclassification.

In this interview clip from our July/August issue, Carly Bader explains how preventing cannabis contamination requires a system-based approach, including routine monitoring of the entire cultivation environment.

Conventional approaches for determining limits of detection (LOD), such as signal-to-noise ratios and repeated measurement methods designed for single-signal detection, can result in unrealistic LOD values because they often fail to account for multi-signal identification and the disproportionate generation of analyte and noise signals in mass spectrometry techniques such as selected ion monitoring (SIM) and multiple reaction monitoring (MRM). This article proposes a practical alternative compared to standard approaches.

Using Raman spectroscopy to measure potency in wet hemp and cannabis plant material would allow cultivators to analyze plants in the field without having to dry them. In experiments testing this methodology, Raman scans were able to correctly classify 93% of hemp samples as being above or below 0.35% total THC, and in cannabis, analysis of total THC had a relative error rate of 6%, which is below the 10% error rate allowed by many jurisdictions.

In collaboration with the California Department of Cannabis Control (DCC), the new feature is anticipated to increase direct access to recall information.

A bipartisan group of state and territorial attorneys general have called for Congress to enact the SAFER Banking Act or similar legislation to help with cannabis banking in the industry.

Using an optimized analytical method for this research, the phenolics of cannabis were tested resulting in new findings.

Minnesota DEED grants $3.6 million to help new businesses in the cannabis industry.

Researchers investigated the role cannabis use may play in elevating the risk of kidney disease.

The FDA-funded study found that CBD was linked to elevated liver enzymes in some healthy adults, underscoring need for further safety research.

Here, we bring you our top four recent articles covering research on cannabinoids and sleep, why enrolled patients turn to illegal cannabis, using spent hemp biomass as livestock feed, and testing cannabinoids on breath after ingesting edibles.

The researchers measured the amount of THC and other cannabinoids on participants’ breaths, with results demonstrating an increase in THC concentration from baseline samples.

The exploratory analysis suggest that lower costs and reliable supply could affect reliance on illegal medical cannabis in Utah.

The study tracks how THC and CBD levels in cow milk, plasma, and fat tissue change during hemp feed intake and withdrawal periods.

In the second part of this webinar coverage, Dustin Sulak, DO, explains recent research and studies on cannabinoids and their effect on sleep and conditions affecting sleep.

Here, we bring you our top five recent articles covering National CBD Day 2025, medical cannabis patients’ workers’ compensation, Trump looking into cannabis rescheduling, research studies on cannabis for sleep, and a clinical trial for CBD and insomnia.

In this month’s webinar, Dustin Sulak, DO, explains recent research and studies on cannabinoids and their effect on sleep and conditions affecting sleep.

Dispensary 33 budtenders have joined Teamsters Local 777 and will collaborate further with the organization on future projects.

The referral-based partnership aims to provide cannabis businesses with comprehensive solutions that merge compliance, payroll, insurance, and risk management services.

Avecho Biotechnology Limited is looking to recruit more than 500 patients for a clinical trial evaluating the use of a pharmaceutical CBD product to treat insomnia.

President Trump recently stated interest in considering the reclassification of cannabis with an update on the decision anticipated within the coming weeks. Industry stakeholders, including CST blog author Kim Anzarut, weigh in.

In honor of National CBD Day on August 8, 2025, we are excited to share with you our CBD-themed round up of CBD research.

House Bill 1766 proposes that qualifying employees receive up to $250 monthly and $3000 annually for approved medical cannabis purchases.

In honor of National CBD Day on August 8, 2025, we are excited to share with you our CBD-themed round up of CBD-related medical research.

Here, we bring you our top five recent articles covering multiple stories on adult-use cannabis sales in Delaware, the top compliance issues in 2025, and research on how medical cannabis affects healthcare utilization by chronic pain patients.

Check out our exciting 2025 National CBD Day coverage!

Analysis of two coffee products revealed 70–80% less CBD in the brewed coffee than what was indicated on the label.